Legal Representation
Attorney
Milica Bosnjak
USPTO Deadlines
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 16, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 16, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 12, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 16, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 15, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 15, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 5, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 5, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 5, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 12, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 11, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 15, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biological preparations for the treatment of cancer, immunological-inflammatory and other chronic conditions; Biological products, namely, a drug delivery system comprising antibodies or antibody fragments which extend the effect of a wide variety of therapeutic agents, for medical use and for use in medical treatment; Diagnostic preparations for medical purposes; Vaccines for human use; Therapeutic vaccines; Medical preparations, namely, antibodies and antibody fragments, for treatment of inflammatory diseases, neoplastic diseases, autoimmune diseases, and cancer; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Pharmaceutical preparations for the treatment and/or prophylaxis of chronic disease
Additional Information
Design Mark
The mark consists of the literal element "CHANTIBODY" in stylized font along with a radial three-loop design element in the upper right corner.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "CHANTIBODY" has no meaning in a foreign language.
Classification
International Classes
005